Simple blood test could spare prostate cancer patients from unnecessary scans
NCT ID NCT07553754
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study aims to develop a blood test that detects RNA from tiny particles (exosomes) to predict if prostate cancer has spread to the bones. Researchers will analyze blood samples from 1,000 men with newly diagnosed prostate cancer and compare results with PSMA PET scans. The goal is to create a test that can reliably rule out bone metastasis, potentially reducing the need for expensive imaging in low-risk patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Plasma exosomal RNA signature (liquid biopsy test)
- What this could lead to
- If successful, this blood test could safely rule out bone metastasis in low-risk prostate cancer patients, avoiding unnecessary PSMA PET scans and reducing healthcare costs.
- What could go wrong
- This is an early-phase diagnostic study with a target specificity of only 30%, meaning many patients may still need imaging. The test is not yet validated for routine clinical use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BIOMARKER DISCOVERY AND VALIDATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Affiliated Hospital of Yan'an University
RECRUITINGYan’an, Shaanxi, China
-
General Hospital of Ningxia Medical University
RECRUITINGYinchuan, Ningxia, China
-
Qinghai University Affiliated Hospital
RECRUITINGXining, Shaanxi, China
-
Shaanxi Provincial People's Hospital
RECRUITINGXi'an, Shaanxi, China
-
The First Hospital of Lanzhou University
RECRUITINGLanzhou, Gansu, China
-
The Second Affiliated Hospital of Shaanxi University of Chinese Medicine
RECRUITINGXianyang, Shaanxi, China
-
Weinan Central Hospital
RECRUITINGWeinan, Shaanxi, China
-
Xijing 986 Hospital
RECRUITINGXi'an, Shaanxi, China
-
Xijing Hospital
RECRUITINGXi'an, Shaanxi, 710032, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A sharper eye on prostate cancer return: PSMA PET vs. MRI
- Sound waves could make brain tumor diagnosis safer and smarter
- AI may help spot dangerous prostate cancer and spare men from needless biopsies
- Gum disease clues: could hippo proteins be the missing link?
- Blood test may spot prostate cancer without a needle
- AI reads scans to spot prostate cancer, spare unnecessary biopsies